Description

Send us Fan Mail

In this episode, I'm joined by Scott Lyman, CEO and Co-Founder of Belhaven BioPharma, to discuss Nasdepi®, an investigational dry powder epinephrine nasal spray currently in development for the treatment of anaphylaxis.

Nasdepi® is designed as a needle-free alternative to traditional auto-injectors, with early clinical data suggesting rapid absorption and strong temperature stability.

We talk about:

• Why alternative delivery systems matter
• Needle fears and other real-world barriers to carrying epinephrine
• Human factor studies and ease of use in high-stress situations
• What “investigational” means and where the product stands in development

This episode is part of a broader series exploring epinephrine options beginning with episode 67. As always, this podcast does not promote any specific product, just information and education. 

Episode links:
-Nasdepi: https://belhavenbio.com/nasdepi-progress/

Special thanks to Kyle Dine for permission to use his song The Doghouse for the podcast theme!
www.kyledine.com

Find Dr. Whitehouse:
-thefoodallergypsychologist.com
-Instagram: @thefoodallergypsychologist
-Facebook: Dr. Amanda Whitehouse, Food Allergy Anxiety Psychologist
-welcome@dramandawhitehouse.com